Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44-Reference-Cited by-同舟云学术

Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44

Published:2010-09-29 Issue:42 Volume:49 Page:9106-9112
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Somasunderam Anoma¹²,Thiviyanathan Varatharasa¹,Tanaka Takemi²³,Li Xin¹,Neerathilingam Muniasamy¹,Lokesh Ganesh Lakshmana Rao¹,Mann Aman²,Peng Yang²,Ferrari Mauro²⁴³⁵,Klostergaard Jim⁶,Gorenstein David G.¹²

Affiliation:

1. Institute of Molecular Medicine

2. Department of Nanomedicine and Biomedical Engineering

3. Department of Biomedical Engineering, University of Texas, Austin, Texas 78712, United States

4. Department of Bioengineering, Rice University, Houston, Texas 77005, United States

5. Department of Experimental Therapeutics

6. Department of Molecular and Cellular Oncology

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi1009503

Reference52 articles.

1. CD44: Structure, Function and Association with the Malignant Process

2. DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis

3. Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration

4. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APTAMERS: NANOMATERIALS AS A POTENTIAL AGENT FOR ANTIVIRAL THERAPEUTIC DRUG DELIVERY DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW;International Journal of Applied Pharmaceutics;2024-01-07

2. Selection of DNA aptamer recognizing CD44 for high-eﬃciency capture of circulating tumor cells;Talanta;2023-09

3. CD71/CD44 dual-aptamer-gemcitabine conjugate for tumor co-targeting treatment of bladder cancer;Chemical Engineering Journal;2023-05

4. Aptamer-Based Strategies to Boost Immunotherapy in TNBC;Cancers;2023-03-28

5. CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting;European Polymer Journal;2023-01